BTIG Downgrades Heartware Int'l (HTWR) to Neutral
BTIG downgraded Heartware Int'l (NASDAQ: HTWR) from Buy to Neutral. The change follows its acquisition of Valtech.
"While we understand the rationale of this acquisition and it may prove to be a strong asset over the next 3-5 years, we anticipate there will be significant investor turnover and no longer see upside within BTIG’s 12 month rating system," said analyst Sean Lavin.
For an analyst ratings summary and ratings history on Heartware Int'l click here. For more ratings news on Heartware Int'l click here.
Shares of Heartware Int'l closed at $81.81 yesterday.